A novel psoralen derivative-MPFC enhances melanogenesis via activation of p38 MAPK and PKA signaling pathways in B16 cells

Yin,Li; Pang,Guangxian; Niu,Chao; Habasi,Maidina; Dou,Jun; Aisa,Haji  Akber

doi:10.3892/ijmm.2018.3529

A novel psoralen derivative-MPFC enhances melanogenesis via activation of p38 MAPK and PKA signaling pathways in B16 cells

Authors:
- Li Yin
- Guangxian Pang
- Chao Niu
- Maidina Habasi
- Jun Dou
- Haji Akber Aisa
View Affiliations

Affiliations: The Key Laboratory of Plant Resources and Chemistry of Arid Zone, Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Urumqi, Xinjiang 830011, P.R. China
Published online on: March 2, 2018 https://doi.org/10.3892/ijmm.2018.3529
Pages: 3727-3735

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As an active compound, psoralen is present in various Chinese herbal medicines and has exhibited significant activity in skin disease treatment. Its derivative 8-methoxypsoralan (8-MOP) is the most commonly used drug to induce repigmentation of vitiligo. In our previous screening assays, 4-methyl-6-phenyl-2H-furo[3,2-g]chromen-2-one (MPFC), a psoralen derivative, was identified as more effective tyrosinase and melanin activator than the positive control 8-MOP in consideration of low doses, as well as low toxicity. The overall purpose of this study was to characterize the melanogenic effect and mechanisms of MPFC in B16 cells. The melanin biosynthesis effects of MPFC were determined by examination of cellular melanin contents, tyrosinase activity assay, cyclic adenosinemonophosphate (cAMP) assay, and western blotting of MPFC-stimulated B16 mouse melanoma cells. Our results showed that MPFC enhanced both melanin synthesis and tyrosinase activity in a concentration-dependent manner as well as significantly activated the expression of melanogenic proteins such as tyrosinase, tyrosinase-related protein-1 and tyrosinase-related protein-2. Western blot analysis showed that MPFC increased the phosphorylation of p38 mitogen-activated protein kinase and cAMP response element-binding protein (CREB) as well as the expression of microphthalmia-associated transcription factor (MITF). Moreover, MPFC stimulated intracellular cAMP levels and induced tyrosinase activity and melanin synthesis were attenuated by H89, a protein kinase A inhibitor. These results indicated that MPFC-mediated activation of the p38 MAPK and the protein kinase A (PKA) pathway may shed light on a novel approach for an effective therapy for vitiligo.

View Figures

View References

1	Donata, Kesavan M, Austin, Mohan KS, Rajagopalan K and Kuttan R: Clinical trial of certain ayurvedic medicines indicated in vitiligo. Anc Sci Life. 9:202–206. 1990.PubMed/NCBI
2	Lotti T, Zanardelli M and D'Erme AM: Vitiligo: What's new in the psycho-neuro-endocrine-immune connection and related treatments. Wien Med Wochenschr. 164:278–285. 2014. View Article : Google Scholar : PubMed/NCBI
3	Alikhan A, Felsten LM, Daly M and Petronic-Rosic V: Vitiligo: A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 65:473–491. 2011. View Article : Google Scholar : PubMed/NCBI
4	Silpa-Archa Narumol, Nitayavardhana Sunatra, Thanomkitti Kanchalit, Chularojanamontri Leena, Varothai Supenya and Wongpraparut Chanisada: Comparison of the efficacy and safety of 0.1% tacrolimus ointment and 0.1% mometasonefuroate cream for adult vitiligo: A single-blinded pilot study. Dermatologica Sinica. 34:177–179. 2016. View Article : Google Scholar
5	Park SH, Kim DS, Kim WG, Ryoo IJ, Lee DH, Huh CH, Youn SW, Yoo ID and Park KC: Terrein: A new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci. 61:2878–2885. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hearing VJ: Biochemical control of melanogenesis and melanosomal organization. J Investig Dermatol Symp Proc. 4:24–28. 1999. View Article : Google Scholar : PubMed/NCBI
7	Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR III, Takemori H, et al: The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell. 119:61–74. 2004. View Article : Google Scholar : PubMed/NCBI
8	Zhou J, Shang J, Ping F and Zhao G: Alcohol extract from Vernonia anthelmintica (L.) willd seed enhances melanin synthesis through activation of the p38 MAPK signaling pathway in B16F10 cells and primary melanocytes. J Ethnopharmacol. 143:639–647. 2012. View Article : Google Scholar : PubMed/NCBI
9	Kim HJ, Kim JS, Woo JT, Lee IS and Cha BY: Hyperpigmentation mechanism of methyl 3,5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase. Acta Biochim Biophys Sin (Shanghai). 47:548–556. 2015. View Article : Google Scholar
10	Hemesath TJ, Price ER, Takemoto C, Badalian T and Fisher DE: MAP kinase links the transcription factor microphthalmia to c-Kit signalling in melanocytes. Nature. 391:298–301. 1998. View Article : Google Scholar : PubMed/NCBI
11	Price ER, Ding HF, Badalian T, Bhattacharya S, Takemoto C, Yao TP, Hemesath TJ and Fisher DE: Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem. 273:17983–17986. 1998. View Article : Google Scholar : PubMed/NCBI
12	Shen T, Heo SI and Wang MH: Involvement of the p38 MAPK and ERK signaling pathway in the anti-melanogenic effect of methyl 3,5-dicaffeoyl quinate in B16F10 mouse melanoma cells. Chem Biol Interact. 199:106–111. 2012. View Article : Google Scholar : PubMed/NCBI
13	El Mofty AM: Vitiligo and Psoralens. Pergamon Press; Oxford: pp. 1147–1195. 1968
14	Fitzpatrick TB, Parrish JA and Pathak MA: Phototherapy of vitiligo (idiopatic leukodermia). Sunlight and Man: Normal and abnormal photobiologic responses. Tokyo University Press; Tokyo: pp. 783–791. 1974
15	Parrish JA, Fitzpatrick TB, Shea C and Pathak MA: Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol. 112:1531–1534. 1976. View Article : Google Scholar : PubMed/NCBI
16	Jois HS, Manjunath BL and Venkatarao SJ: Chemical examination of the seeds of Psoralea corylifolia. J Indian Chem Soc. 10:411933.
17	Späth E and Kainrath P: Über Bergamottin und über die Auffindung von Limettin im Bergamottöl (XXXIV. Mitteil. über natürliche Cumarine). Ber Dtsch Chem Ges. 70:2272–2276. 1937.In German. View Article : Google Scholar
18	Felsten LM, Alikhan A and Petronic-Rosic V: Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. J Am Acad Dermatol. 65:493–514. 2011. View Article : Google Scholar : PubMed/NCBI
19	Tippisetty S, Goudi D, Mohammed AW and Jahan P: Repair efficiency and PUVA therapeutic response variation in patients with vitiligo. Toxicol In Vitro. 27:438–440. 2013. View Article : Google Scholar
20	Niu C, Pang GX, Li G, Dou J, Nie LF, Himit H, Kabas M and Aisa HA: Synthesis and biological evaluation of furocoumarin derivatives on melanin synthesis in murine B16 cells for the treatment of vitiligo. Bioorg Med Chem. 24:5960–5968. 2016. View Article : Google Scholar : PubMed/NCBI
21	Niu C, Yin L, Nie LF, Dou J, Zhao JY, Li G and Aisa HA: Synthesis and bioactivity of novel isoxazole chalcone derivatives on tyrosinase and melanin synthesis in murine B16 cells for the treatment of vitiligo. Bioorg Med Chem. 24:5440–5448. 2016. View Article : Google Scholar : PubMed/NCBI
22	Li HR, Habasi M, Xie LZ and Aisa HA: Effect of chlorogenic acid on melanogenesis of B16 melanoma cells. Molecules. 19:12940–12948. 2014. View Article : Google Scholar : PubMed/NCBI
23	Tuerxuntayi A, Liu YQ, Tulake A, Kabas M, Eblimit A and Aisa HA: Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells. BMC Complement Altern Med. 14:166–174. 2014. View Article : Google Scholar : PubMed/NCBI
24	Westerhof W and d'Ischia M: Vitiligo puzzle: The pieces fall in place. Pigment Cell Res. 20:345–359. 2007.PubMed/NCBI
25	Spritz RA: The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 20:271–278. 2007. View Article : Google Scholar : PubMed/NCBI
26	Guerra L, Dellambra E, Brescia S and Raskovic D: Vitiligo: Pathogenetic hypotheses and targets for current therapies. Curr Drug Metab. 11:451–467. 2010. View Article : Google Scholar : PubMed/NCBI
27	Taieb A, Alomar A, Böhm M, Dell'anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, et al Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europeenne des Medecins Specialistes (UEMS): Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol. 168:5–19. 2013. View Article : Google Scholar
28	Eun JS, Kim KS, Kim HN, Park SA, Ma TZ, Lee KA, Kim DK, Kim HK, Kim IS, Jung YH, et al: Synthesis of psoralen derivatives and their blocking effect of hKv1.5 channel. Arch Pharm Res. 30:155–160. 2007. View Article : Google Scholar : PubMed/NCBI
29	Grass JA, Hei DJ, Metchette K, Cimino GD, Wiesehahn GP, Corash L and Lin L: Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood. 91:2180–2188. 1998.
30	Chakraborty DP, Roy S and Chakraborty AK: Vitiligo, psoralen, and melanogenesis: Some observations and understanding. Pigment Cell Res. 9:107–116. 1996. View Article : Google Scholar : PubMed/NCBI
31	Kanof NB: Melanin formation in vitiliginous skin under the influence of external applications of 8-methoxypsoralen. J Invest Dermatol. 24:5–10. 1955. View Article : Google Scholar : PubMed/NCBI
32	Lei TC, Virador V, Yasumoto K, Vieira WD, Toyofuku K and Hearing VJ: Stimulation of melanoblast pigmentation by 8-methoxypsoralen: The involvement of microphthalmia-associated transcription factor, the protein kinase a signal pathway, and proteasome-mediated degradation. J Invest Dermatol. 119:1341–1349. 2002. View Article : Google Scholar : PubMed/NCBI
33	Park HY and Gilchrest BA: Signaling pathways mediating melanogenesis. Cell Mol Biol (Noisy-le-grand). 45:919–930. 1999.
34	Bellei B, Maresca V, Flori E, Pitisci A, Larue L and Picardo M: p38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem. 285:7288–7299. 2010. View Article : Google Scholar : PubMed/NCBI
35	Ye Y, Chu JH, Wang H, xu H, Chou GX, Leung AK, Fong WF and Yu ZL: Involvement of p38 MAPK signaling pathway in the anti-melanogenic effect of San-bai-tang, a Chinese herbal formula, in B16 cells. J Ethnopharmacol. 132:533–535. 2010. View Article : Google Scholar : PubMed/NCBI
36	Kim DS, Jeong YM, Park IK, Hahn HG, Lee HK, Kwon SB, Jeong JH, Yang SJ, Sohn UD and Park KC: A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells. Biol Pharm Bull. 30:180–183. 2007. View Article : Google Scholar : PubMed/NCBI
37	Bu J, Ma PC, Chen ZQ, Zhou WQ, Fu YJ, Li LJ and Li CR: Inhibition of MITF and tyrosinase by paeonol-stimulated JNK/SAPK to reduction of phosphorylated CREB. Am J Chin Med. 36:245–263. 2008. View Article : Google Scholar : PubMed/NCBI
38	Oka M, Nagai H, Ando H, Fukunaga M, Matsumura M, Araki K, Ogawa W, Miki T, Sakaue M, Tsukamoto K, et al: Regulation of melanogenesis through phosphatidylinositol 3-kinase-Akt pathway in human G361 melanoma cells. J Invest Dermatol. 115:699–703. 2000. View Article : Google Scholar : PubMed/NCBI
39	Khaled M, Larribere L, Bille K, Aberdam E, Ortonne JP, Ballotti R and Bertolotto C: Glycogen synthase kinase 3beta is activated by cAMP and plays an active role in the regulation of melanogenesis. J Biol Chem. 277:33690–33697. 2002. View Article : Google Scholar : PubMed/NCBI
40	Hirata N, Naruto S, Ohguchi K, Akao Y, Nozawa Y, Iinuma M and Matsuda H: Mechanism of the melanogenesis stimulation activity of (−)-cubebin in murine B16 melanoma cells. Bioorg Med Chem. 15:4897–4902. 2007. View Article : Google Scholar : PubMed/NCBI
41	Ganss R, Schütz G and Beermann F: The mouse tyrosinase gene. Promoter modulation by positive and negative regulatory elements. J Biol Chem. 269:29808–29816. 1994.PubMed/NCBI